Statera Biopharma, Inc. Operating Lease Right-of-Use Assets
Statera Biopharma, Inc. had Operating Lease Right-of-Use Assets of $914.23 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2022-11-14
- 2022-09-30: Operating Lease, Right-of-Use Asset $914.23K.
- 2022-06-30: Operating Lease, Right-of-Use Asset $1.06M.
- 2022-03-31: Operating Lease, Right-of-Use Asset $1.13M.
- 2021-12-31: Operating Lease, Right-of-Use Asset $964.33K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2022-09-30 | $914.23K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.06M 10-Q · filed 2022-10-28 |
| 2022-03-31 | $1.13M 10-Q · filed 2022-10-21 |
| 2021-12-31 | $964.33K 10-Q · filed 2022-11-14 |
| 2021-09-30 | $840.59K 10-Q · filed 2021-11-15 |
| 2020-12-31 | $101.05K 10-K · filed 2022-10-06 |
| 2020-12-30 | $101.05K 10-Q · filed 2021-11-15 |